Pemigatinib is a drug that focuses onFGFR2 fusions. It’s often used to treat cholangiocarcinoma. It comes in three sizes – 4.5 mg, 9 mg, and the biggest one, which is 13.5 mg.
The suggested amount to take is 13.5 mg, just once a day for 14 days, every 21 days. The medicine comes in bottles with 14 tablets in each one.
